Google Ads Health Advertising: What Sensitive Category Rules Mean

Google’s personalized advertising policy restricts how advertisers can target users based on sensitive health information. For health sector advertisers, this means you cannot use audience signals tied to medical conditions, diagnoses, or health status to serve personalized ads, and Google enforces this at the campaign and creative level, not just in the data layer.

The practical effect is significant. Remarketing lists, custom audiences, and third-party data segments that touch on health conditions are either blocked outright or subject to restrictions that limit who sees your ads and how. Understanding where those lines sit is not a compliance exercise. It is a strategic one.

Paid advertising in regulated categories is one of the areas where I see the most avoidable mistakes. Teams either ignore the rules until an account gets flagged, or they become so cautious they gut their own campaigns. Neither approach serves the business. If you want a broader grounding in how paid channels fit into a performance marketing strategy, the Paid Advertising hub covers the full landscape.

What Does Google’s Personalized Advertising Policy Actually Cover?

Google’s personalized advertising policy identifies several sensitive interest categories where targeting based on personal characteristics is either restricted or prohibited. Health and medical conditions sit near the top of that list. The policy covers conditions including physical and mental health diagnoses, disabilities, pharmaceutical use, and genetic information.

What this means in practice: you cannot build a remarketing audience from users who visited a page about a specific medical condition and then target them with ads referencing that condition. You cannot purchase or upload third-party audience data that segments users by health status. You cannot use Google’s own audience tools, including affinity audiences and in-market segments, in ways that proxy for health conditions.

The policy is broader than most advertisers initially assume. It is not just about explicitly labeling someone as having a condition. It is about the inference. A list of people who visited a cancer treatment page is a health-sensitive audience whether or not you call it that. Google’s systems are designed to detect this, and the enforcement consequences are real.

I have seen this catch out sophisticated teams. During my time running agency operations across healthcare and pharmaceutical clients, the assumption was often that if the audience was built from first-party data and not explicitly labeled, it was fine. That assumption does not hold. The policy looks at what the data represents, not just what it is called.

Which Targeting Methods Are Still Available to Health Advertisers?

The restrictions on personalized advertising do not eliminate the ability to run effective campaigns in health. They redirect it. Contextual targeting remains fully available. Keyword-based Search campaigns are not subject to the same personalization restrictions because they respond to intent signals at the moment of search rather than building audience profiles over time.

This distinction matters more than most teams realize. A Search campaign targeting queries like “private GP appointment London” or “anxiety therapy near me” is operating on expressed intent. The user is telling you what they want right now. That is fundamentally different from tracking someone across the web because they read an article about diabetes three weeks ago.

On Display and YouTube, contextual targeting by placement, topic, and keyword allows health advertisers to reach relevant audiences without relying on personal health signals. You can target pages about nutrition, fitness, or general wellness without triggering sensitive category restrictions. The line sits at condition-specific targeting and anything that implies a diagnosis or treatment need.

First-party CRM data can still be used, but with important caveats. Customer match lists built from existing patients or subscribers are permissible provided they do not encode health status information. A list of newsletter subscribers is different from a list of patients with a particular condition. The former is fine. The latter is not.

There is also a meaningful role for broad match and smart bidding in health campaigns. When you cannot micro-segment audiences by condition, the quality of your keyword architecture and your bidding strategy carry more weight. Building well-structured Google Ads campaigns becomes the primary lever for efficiency rather than audience refinement.

How Does This Policy Apply Differently Across Search, Display, and YouTube?

The sensitive categories policy applies across all Google Ads products, but the enforcement mechanics differ by channel, and understanding those differences helps you build campaigns that are both compliant and effective.

On Search, the primary risk area is not the targeting itself but the ad content and landing page. Google reviews whether ads contain content that implies knowledge of a user’s health condition. An ad that says “We know you’re struggling with depression” crosses the line regardless of how the audience was built. The targeting restrictions on Search are less about audience signals and more about the relationship between ad copy and implied personal knowledge.

On Display, the audience-level restrictions are more prominent. Remarketing lists, similar audiences, and custom intent segments all carry risk if they are built from health-sensitive browsing behavior. Google Display Ads offer reach and targeting depth that can work well for health advertisers, but the architecture needs to be built around contextual signals rather than behavioral health data.

YouTube sits in a similar position to Display. Audience targeting that draws on health-sensitive signals is restricted, but content-based targeting by channel, video topic, or keyword remains available. Health advertisers running awareness campaigns on YouTube can reach relevant audiences through placement targeting on health and wellness content without building condition-specific audience lists.

The practical implication: you need to audit your targeting setup separately for each channel. A campaign structure that is compliant on Search may not be compliant on Display if it is using shared remarketing lists that contain health-sensitive signals. This is one of the most common mistakes in PPC advertising in regulated categories: assuming that what works in one channel transfers cleanly to another.

What Are the Consequences of Getting This Wrong?

Google’s enforcement on sensitive category violations is not gradual. Accounts can be suspended without extended warning periods, and reinstatement requires a formal appeal process that can take weeks. For health businesses that rely on paid search for patient acquisition or lead generation, a suspension is not an inconvenience. It is a revenue event.

Beyond account-level consequences, there is a reputational dimension. Health advertising that appears to exploit personal medical information, even if the advertiser did not intend it that way, creates trust problems with the audience you are trying to reach. Patients are not a generic consumer segment. The relationship between a health provider and a potential patient starts before the first appointment, and how you advertise shapes that relationship.

I judged the Effie Awards for several years. One thing that struck me consistently in the health category was how rarely effectiveness was connected to trust. Campaigns that drove short-term conversion metrics sometimes created long-term brand problems because the targeting felt intrusive. The policy restrictions Google imposes are, in part, a floor that protects advertisers from themselves.

There is also a legal layer. Depending on jurisdiction, health data handling intersects with GDPR in the UK and EU, HIPAA in the US, and various national health data regulations. Google’s policy compliance does not guarantee legal compliance. These are separate frameworks, and advertisers operating in health need to be across both.

How Should Health Advertisers Structure Campaigns to Stay Compliant and Perform?

The starting point is a clean audit of your current audience lists. If you are running remarketing campaigns and your website serves health-specific content, you need to understand what signals those lists are capturing. A blanket remarketing list built from all site visitors is generally fine. A list built specifically from visitors to a page about a named condition is not.

The solution is usually URL-level exclusions in your remarketing tag setup. You can exclude condition-specific pages from your remarketing audience while still building lists from general site traffic, appointment booking pages, and non-condition content. This requires a deliberate tagging strategy rather than a catch-all approach.

For Display and YouTube campaigns, build your targeting architecture around content rather than audience. Topic targeting, placement targeting on relevant health and wellness content, and keyword contextual targeting all give you meaningful reach without touching sensitive audience signals. The trade-off is slightly less precision, but the compliance risk is dramatically lower.

On Search, the focus shifts to keyword strategy and ad copy discipline. Broad intent queries, symptom-based searches, and treatment-seeking queries are all accessible through standard keyword targeting. The ad copy needs to be informational and helpful rather than implying personal knowledge of the user’s condition. “Specialist appointments available this week” is fine. “We know you’re looking for help with your condition” is not.

When I was at iProspect and we were scaling the business from around 20 people to over 100, health and pharmaceutical clients were among the most complex to manage precisely because the gap between what was technically possible and what was permissible was so wide. The teams that performed best were the ones who invested time in understanding the policy framework first and built campaign architecture around it, rather than trying to retrofit compliance after the fact.

There is also a creative dimension worth considering. When audience targeting is constrained, creative quality carries more weight. An ad that communicates clearly, builds trust, and speaks to the user’s intent without feeling intrusive will outperform one that tries to compensate for targeting limitations with aggressive messaging. This is not a soft observation. When I launched a paid search campaign at lastminute.com for a major music festival, the performance came from tight keyword-to-creative alignment and a clear value proposition, not from sophisticated audience layering. The same principle applies in health: clarity and relevance in the ad itself matter more than most advertisers give them credit for.

It is also worth noting that the advantages of PPC advertising in health are still substantial even within these constraints. Paid search captures active treatment-seeking intent at the exact moment it occurs. No other channel does that at scale. The policy restrictions limit how you build and layer audiences. They do not limit the fundamental value of being present when someone searches for the service you provide.

Where Does This Leave Health Advertisers on Broader Paid Strategy?

Google Ads is not the only channel available to health advertisers, and the sensitive category restrictions on personalized advertising make it worth thinking carefully about channel mix. Paid social platforms have their own health advertising restrictions, and they vary significantly. Meta, for example, has removed detailed targeting options in health-related categories entirely in some markets. The restrictions are industry-wide, not Google-specific.

This is where developing a paid advertising strategy that accounts for channel-specific constraints from the outset becomes genuinely important. If you build a strategy that assumes the same audience targeting capabilities across all channels, you will hit compliance walls in execution. The strategy needs to be built around what each channel can actually do in your category.

Influencer marketing is one area where health advertisers sometimes look for alternatives to constrained paid channels. The dynamics are different, but the regulatory considerations are not simpler. The distinction between paid and organic influencer usage matters in health because disclosure requirements and advertising standards apply differently depending on whether content is paid for or editorially independent. It is not a clean escape from the compliance landscape.

There is also a B2B dimension to health advertising that often gets overlooked. Medical device companies, healthcare technology businesses, and pharmaceutical companies targeting healthcare professionals operate under different rules than direct-to-consumer health advertisers. The sensitive category restrictions on personalized advertising are primarily designed around consumer protection. B2B health campaigns targeting clinicians or procurement teams sit in a different part of the policy framework. Who designs high-performing ads for B2B in health is a genuinely different question from who builds effective consumer health campaigns, and the compliance architecture reflects that.

The vendors selling AI-driven personalized creative solutions to health advertisers deserve particular scrutiny here. I have sat in presentations where the claimed performance uplifts were extraordinary, and the explanation was always some variant of machine learning doing something magical with audience signals. When you dig into the methodology, the baseline was usually so weak that any competent campaign would have shown the same improvement. The sensitive category restrictions on health mean that some of the personalization capabilities these vendors are selling are not actually available to you in this category. Ask that question explicitly before you sign anything.

Google’s own policy documentation has evolved considerably over the years. The platform has a long history of policy changes that catch advertisers off guard, and health has consistently been one of the most actively managed categories. Building a compliance review into your campaign audit cycle, rather than treating it as a one-time setup task, is the only sustainable approach.

For advertisers who want to understand how organic and paid search interact in health, the comparison between SEO and Google Ads is useful context. In health, organic search often captures the same intent signals that paid search targets, and the two channels can either reinforce or cannibalize each other depending on how they are managed. A paid strategy that ignores the organic landscape is leaving efficiency on the table.

There is a version of health advertising that works well within these constraints. It requires more discipline in campaign architecture, more investment in creative quality, and a clearer understanding of where the policy lines actually sit. The advertisers who perform consistently in this category are not the ones who find clever workarounds. They are the ones who build campaigns that do not need them. If you want to go deeper on how paid channels fit into a broader acquisition strategy, the full Paid Advertising resource section covers the mechanics across channels and formats.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions